Accéder au contenu
Merck

Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.

Molecular psychiatry (2015-03-11)
C Yuksel, F Du, C Ravichandran, J R Goldbach, T Thida, P Lin, B Dora, J Gelda, L O'Connor, S Sehovic, S Gruber, D Ongur, B M Cohen
RÉSUMÉ

Converging evidence suggests bioenergetic abnormalities in bipolar disorder (BD). In the brain, phosphocreatine (PCr) acts a reservoir of high-energy phosphate (HEP) bonds, and creatine kinases (CK) catalyze the transfer of HEP from adenosine triphosphate (ATP) to PCr and from PCr back to ATP, at times of increased need. This study examined the activity of this mechanism in BD by measuring the levels of HEP molecules during a stimulus paradigm that increased local energy demand. Twenty-three patients diagnosed with BD-I and 22 healthy controls (HC) were included. Levels of phosphorus metabolites were measured at baseline and during visual stimulation in the occipital lobe using (31)P magnetic resonance spectroscopy at 4T. Changes in metabolite levels showed different patterns between the groups. During stimulation, HC had significant reductions in PCr but not in ATP, as expected. In contrast, BD patients had significant reductions in ATP but not in PCr. In addition, PCr/ATP ratio was lower at baseline in patients, and there was a higher change in this measure during stimulation. This pattern suggests a disease-related failure to replenish ATP from PCr through CK enzyme catalysis during tissue activation. Further studies measuring the CK flux in BD are required to confirm and extend this finding.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2,2′:5′,2′′:5′′,2′′′-Quaterthiophene, 96%